2012-000543-27: A randomized, double-blind study to investigate the mechanism of Nanocort® in humans. |
|
|
| Ongoing | 2 | 20 | Europe | Nanocort, Powder for solution for infusion | AMC, AMC | Vessel wall inflammation, Cardiovascular disease, Diseases [C] - Cardiovascular Diseases [C14] | | | | |
2017-001158-33: A pilot study towards a therapy with prednisolone encapsulated liposomes for the treatment of Graves’ Orbitopathy with reduced systemic steroid exposure |
|
|
| Ongoing | 2 | 20 | Europe | Nanocort, Concentrate and solvent for solution for infusion | The Rotterdam Eye Hospital, Rotterdamse Stichting Blindenbelangen, Enceladus Pharmaceuticals | Graves' Orbitopathy, Graves' Orbitopathy, Diseases [C] - Immune System Diseases [C20] | | | | |
